/PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) today announced that data from a recent study evaluating the efficacy and safety of... ...http://in.sys-con.com/node/3003324
Novartis announced that the European Commission (EC) has approved the use of Xolair (omalizumab) as an add-on therapy for the treatment of chronic... ...http://www.pharmabiz.com/NewsDetails.aspx?aid=80784&sid=2
Comments - LondonNo Novartis International AG / . Processed and transmitted by NASDAQ OMX Corporate Solutions.The issuer is solely responsible for... ...http://andhranews.net/Business/2014/Novartis-Xolair-approved-EU-first-licensed-10429.htm
Namita, a 33-year old female, complained that three hours before visiting us, a few pimples accompanied with extreme itching appeared unexpectedly... ...http://www.newindianexpress.com/lifestyle/health/Quelling-the-Red-Itching-Flamingo/2014/03/02/article2082313.ece
Urticaria Solution designed by Nancy Summer is the latest program for those people who want to get rid of irritating and embarrassing hives. A full... ...http://www.bizwireexpress.com/showstoryPRWeb.php?storyid=158346
Read the best and honest review on...